HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosisAlexius Ramcharan, Carine J.M. Doggen, Frits R. Rosendaal et al.|Journal of Thrombosis and Haemostasis|2008Cited by 101